Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 48 | Mind Blowing Facts

A vibrating pill could help treat obesity, pig study finds

Pigs that swallowed the vibrating pill before meals ate around 40% less than those that did not, according to the study.

LiveScience

This Vibrating "Pill" May Be the Next Best Thing For Weight Loss

In a new study, MIT engineers design an ingestible vibrating pill for weight loss, one that could be a minimally invasive, cost-effective treatment for obesity.

Inverse

'It could change lives': Inside London lab testing gene therapy for cancer and obesity

Meira GTx, in Shoreditch, is working on potentially revolutionary treatments for a wide array of illnesses

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Tax ‘HFSS’ foods, view it as a public health imperative

Effectively designed taxes can reap multiple benefits such as acting as a deterrent to consuming High Fat Sugar Salt (HFSS) foods and reducing the burden on the health-care system

The Hindu

Plastics, pesticides and pills: how chemical exposures affect sperm health

Poor diet, stress, smoking and obesity are known factors impairing sperm health, but they don’t paint the entire picture

The Guardian - US

Severe Obesity on the Rise in Preschool-Aged US Children

Study reveals increasing trend in severe obesity among U.S. preschoolers, raising concerns about future potential health issues.

Top News

Study bolsters evidence that severe obesity increasing in young US kids

A new study adds to evidence that severe obesity is becoming more common in young U.S. children

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

More kids skipping fruit, veges as experts raise alarm

More children are turning away from eating the recommended amount of fruit and vegetables, and health experts say action is needed to reverse the trend.

AAP

New obesity medications are changing the way people look at holiday meals

The drugs are shifting not only what people taking them eat but also how they think about food. That can have broad implications around food-centric holidays.

Chicago Sun-Times

Social isolation and loneliness linked to poor health – our study could help explain why

Numerous studies have shown that social isolation and loneliness are associated with an increased risk of early death, on a scale comparable to other known risk factors such as smoking and obesity. This year, the US surgeon general declared social isolation and loneliness to be a significant public health concern.

The Conversation

Patients Regain Much Weight After Stopping New Obesity Drug: Study

A new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.

International Business Times

Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

The Independent UK

Research shows specific genetic variant can help prevent obesity

A preclinical study conducted by Weill Cornell Medicine researchers reveals that a certain human genetic variant of a receptor that increases insulin release may help individuals be more resistant to obesity. Read further on Dynamite News:

Dynamite News

Diabetes Drugs Show Potential In Reducing Colon Cancer Risk

Groundbreaking study suggests type 2 diabetes medications may also ward off other obesity-related cancers

Zenger

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Government inaction on obesity is harming our health

Letter: It’s easy to blame individuals, but real change can only happen if industry and the government take responsibility, says Colette Marshall of Diabetes UK. Plus a letter from Michael Fuller

The Independent UK

David Gandy on modelling, influencers and obesity in the UK: ‘I wasn’t born with this body’

The male supermodel talks to Helen Coffey about body image, how he lost his ‘puppy fat’, his new ‘influencer’ rivals and protecting his daughters from the evils of social media in the age of the internet

Evening Standard

What are the rules around fast-food takeaways and London schools?

In London, a ban on fast-food takeaways opening within 400 metres of schools was put in place in 2017

Dynamite News

Health: Research shows diet has a significant impact on risk of Alzheimer's disease

Alzheimer's disease rates rise in these countries as they make the nutrition transition to the Western diet. Read further on Dynamite News:

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

The Guardian - UK

Cost of people being overweight in UK now £98bn, study finds

Estimate includes £63bn cost to people affected, £19bn cost to NHS and £15bn cost to society

International Business Times

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

The Independent UK

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

Fortune

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

Zepbound is expected to be available in the U.S. by the end of the year.

Zenger

Overweight Teens Face Higher Cancer Risk, Study Shows

Obesity in adolescence linked to up to 17 different cancers, raising concerns about long-term health consequences.

Fortune

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.

1 … 47 48 49 50

People

Lars Fruergaard Jørgensen

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Eli Lilly and Company

60 stories

Weill Cornell Medicine

19 stories

GMU

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.